AQST: Multiplikator P/S Aquestive Pharma
The price-to-sales ratio dynamics help assess the human capital potential of Aquestive Therapeutics (AQST) in developing polymer films and navigating FDA barriers. The innovative method of replacing injections with soluble strips enhances patient comfort, while a stable geopolitical backdrop ensures business security. The value of 10.10 serves as the current parameter value, confirming the fundamental link between share prices and the company's actual commercial success.
Rincian metrik lan analitis perusahaan Aquestive Pharma (AQST)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Aquestive Therapeutics|AQST - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Aquestive Corp|AQST - Gunggung utang perusahaan|Utang marang modal buku Aquestive Pharma|AQST - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Aquestive Therapeutics|Likuiditas cepet aquestive.com
- rincian bathi lan kelipatan pasar:
AQST - Bathi resik|Bathi resik sing dikarepake Aquestive Therapeutics|AQST - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Aquestive Therapeutics Inc|AQST - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Aquestive Pharma|AQST - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Aquestive Therapeutics|AQST - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan aquestive.com|AQST - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Aquestive Therapeutics
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:aquestive.com
The ratio of market capitalization to annual sales measures the cost of one dollar of revenue, which is critical for valuing companies in the commercial launch stage. An analysis of the price/sales multiple for Aquestive Therapeutics (AQST) allows market expectations for its innovative medicinal films to be correlated with actual monetization rates, determining whether the current price is fair relative to historical context and future regulatory approvals.
Perusahaan pesaing
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S KVUE (Kenvue)|Multiplikator P/S Verona Pharma PLC VRNA|MENS - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan Ligand Corp (LGND)|AMRX (Amneal Pharmaceuticals) - Kapitalisasi marang pendapatan|perrigo.com (PRGO) - Multiplikator P/S|ALVO (Alvotech SA) - Multiplikator P/S|Rega marang dodolan Liquidia Corp LQDA|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|Koefisien rega marang pendapatan ANI Pharmaceuticals Corp|MannKind Corporation - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan AMPH (amphastar.com)|Pacira BioSciences, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan ARS Pharmaceuticals Inc SPRY|TBPH (Theravance) - Kapitalisasi marang pendapatan|SCPH (scPharmaceuticals) - Rasio rega marang pendapatan|TECX (Tectonic Therapeutic Inc.) - Multiplikator P/S|Rega marang dodolan tonixpharma.com TNXP|Kapitalisasi marang pendapatan SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Rasio kapitalisasi pasar marang pendapatan|BioHarvest - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan EXOZ (Invizyne)|Oramed Pharma - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ENTX (Entera Bio Ltd.)|HYFT: Multiplikator P/S|Rega marang dodolan ABVC BioPharma Inc. (ABVC)|Rasio rega marang pendapatan Cumberland Pharma|QNTM: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FGEN|Multiplikator P/S telomirpharma.com (TELO)|Rasio rega marang pendapatan Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Rasio rega marang dodolan|Rallybio Corp. - Multiplikator P/S|Rega marang dodolan Lexaria Bioscience|PULM (Pulmatrix, Inc.) - Kapitalisasi marang pendapatan|Pheton Holdings (PTHL) - Multiplikator P/S|Kapitalisasi marang pendapatan APM|LYRA (Lyra Therapeutics Inc.) - Kapitalisasi marang volume dodolan|Multiplikator P/S IBO|Koefisien rega marang pendapatan tnfpharma.com|Multiplikator P/S YCBD (cbdMD)|PRFX - Kapitalisasi marang pendapatan|CYTO - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Lipella Pharmaceuticals Inc LIPO|OPTN: Multiplikator P/S|Pieris Pharma (PIRS) - Multiplikator P/S|Rasio rega marang pendapatan Procaps Group S.A.|PTPI - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Qilian International Holding (QLI)|Koefisien rega marang pendapatan Acelyrin Inc.|TFF Pharma - Kapitalisasi marang pendapatan
